Zepbound’s most common side effects are gastrointestinal: nausea, diarrhea, and vomiting. In clinical trials, roughly 1 in 4 people experienced nausea, and about 1 in 5 had diarrhea. These effects are usually worst during the first few months and tend to ease as your body adjusts. Most people tolerate the medication well enough to continue, but about 4% to 7% of trial participants stopped treatment because of side effects.
Nausea, Diarrhea, and Vomiting
Digestive issues are by far the most reported side effects, and the rates climb slightly with higher doses. In the SURMOUNT clinical trials, nausea affected 25% of people on the lowest dose (5 mg), 29% on 10 mg, and 28% on 15 mg, compared to just 8% on placebo. Diarrhea followed a similar pattern: 19% at 5 mg, 21% at 10 mg, and 23% at 15 mg versus 8% on placebo. Vomiting was less common but still significant, ranging from 8% to 13% across doses.
The good news is that these symptoms are generally front-loaded. The majority of nausea, vomiting, and diarrhea episodes occurred during dose escalation, the period when your dose is being gradually increased, and decreased over time. This is exactly why the prescribing schedule starts at the lowest dose and steps up slowly over several months. If you’re in the early weeks and feeling rough, there’s a reasonable chance it will get better.
How to Manage GI Side Effects
A few practical adjustments can make a real difference while your body adapts. Eating smaller, more frequent meals instead of three large ones reduces the burden on your stomach. Stop eating when you first feel full rather than finishing what’s on your plate. Avoid eating close to bedtime, leaving several hours between your last bite and when you lie down. Staying well hydrated matters even more if nausea is making it hard to eat normally. Ginger, whether steeped in hot water or blended into a smoothie, has solid evidence behind it as a nausea remedy.
Injection Site Reactions
Since Zepbound is a weekly injection, some people notice reactions where the needle goes in. In trials, injection site reactions occurred in 6% to 8% of people on the medication versus 2% on placebo. These reactions included bruising, redness, itching, pain, and rash at the injection site. They’re generally mild and short-lived.
Thyroid Tumor Warning
Zepbound carries the FDA’s most serious warning, a boxed warning, related to thyroid tumors. In animal studies, the active ingredient caused thyroid C-cell tumors in rats. Whether this translates to humans remains unknown. Because of this uncertainty, the drug is contraindicated for anyone with a personal or family history of medullary thyroid carcinoma (a rare type of thyroid cancer) or a condition called Multiple Endocrine Neoplasia syndrome type 2.
This doesn’t mean Zepbound causes thyroid cancer in people. It means the possibility hasn’t been ruled out, and the FDA requires the warning as a precaution. If you notice a lump in your neck, have trouble swallowing, or develop persistent hoarseness, those warrant prompt medical attention.
Pancreatitis Risk
Acute pancreatitis, a sudden and painful inflammation of the pancreas, has been reported in a small number of Zepbound users. In pooled data from the main weight-loss trials, 0.2% of people on the medication experienced confirmed acute pancreatitis, the same rate as the placebo group. That’s a reassuringly low number, but the condition is serious enough that you should know the warning signs: severe abdominal pain, sometimes radiating to the back, that may come with vomiting. This type of pain is distinct from ordinary stomach discomfort. It tends to be intense and persistent.
Slowed Stomach Emptying
Zepbound works partly by slowing how quickly food leaves your stomach, which helps you feel full longer. In some people, this effect can become excessive, leading to a condition sometimes called gastroparesis or stomach paralysis. Symptoms include severe bloating, persistent nausea that doesn’t improve with dietary changes, feeling full after just a few bites, and in some cases vomiting undigested food hours after eating. While formal clinical trial data on gastroparesis rates with Zepbound specifically are limited, the drug works through the same GLP-1 pathway as other medications where this risk has been documented. If you’re experiencing digestive symptoms that feel disproportionate or aren’t improving over time, that’s worth raising with whoever prescribed the medication.
Who Discontinued and When
Not everyone can push through the side effects. In the SURMOUNT-1 trial, discontinuation rates due to adverse events were 4.3% at the 5 mg dose, 7.1% at 10 mg, and 6.2% at 15 mg, compared to 2.6% on placebo. The SURMOUNT-2 trial showed similar numbers: 3.8% at 10 mg and 7.4% at 15 mg. Most people who quit did so during the first few months, driven primarily by GI symptoms. Put differently, the vast majority of people who make it past the initial adjustment period stick with the medication.
The dose escalation schedule exists specifically to reduce this dropout. Jumping straight to a high dose would likely produce more intense side effects. If you’re struggling at a particular dose, your prescriber may keep you at that level longer before stepping up, giving your body more time to adjust.